HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scholl, T. O Search for Related Content PubMed PubMed Citation Articles by Scholl, T. O Agricola Articles by Scholl, T. O

Iron status during pregnancy: setting the stage for mother and infant^1,2,3,4

¹ From the Department of Obstetrics and Gynecology, The University of Medicine and Dentistry of New Jersey - SOM, Stratford, New Jersey 08084

ABSTRACT

Supplementation with iron is generally recommended during pregnancy to meet the iron needs of both mother and fetus. When detected early in pregnancy, iron deficiency anemia (IDA) is associated with a > 2-fold increase in the risk of preterm delivery. Maternal anemia when diagnosed before midpregnancy is also associated with an increased risk of preterm birth. Results of recent randomized clinical trials in the United States and in Nepal that involved early supplementation with iron showed some reduction in risk of low birth weight or preterm low birth weight, but not preterm delivery. During the 3rd trimester, maternal anemia usually is not associated with increased risk of adverse pregnancy outcomes and may be an indicator of an expanded maternal plasma volume. High levels of hemoglobin, hematocrit, and ferritin are associated with an increased risk of fetal growth restriction, preterm delivery, and preeclampsia. While iron supplementation increases maternal iron status and stores, factors that underlie adverse pregnancy outcome are considered to result in this association, not iron supplements. On the other hand, iron supplements and increased iron stores have recently been linked to maternal complications (eg, gestational diabetes) and increased oxidative stress during pregnancy. Consequently, while iron supplementation may improve pregnancy outcome when the mother is iron deficient it is also possible that prophylactic supplementation may increase risk when the mother does not have iron deficiency or IDA. Anemia and IDA are not synonymous, even among low-income minority women in their reproductive years.

Key Words: Anemia • iron deficiency • ferritin • oxidative stress • preterm delivery • low birth weight • gestational diabetes • iron • supplementation • pregnancy

This article has been cited by other articles:

				S Palma, R Perez-Iglesias, D Prieto, R Pardo, J Llorca, and M Delgado-Rodriguez Iron but not folic acid supplementation reduces the risk of low birthweight in pregnant women without anaemia: a case control study J. Epidemiol. Community Health, February 1, 2008; 62(2): 120 - 124. [Abstract] [Full Text] [PDF]

				R. J. Edison, K. Berg, A. Remaley, R. Kelley, C. Rotimi, R. E. Stevenson, and M. Muenke Adverse Birth Outcome Among Mothers With Low Serum Cholesterol Pediatrics, October 1, 2007; 120(4): 723 - 733. [Abstract] [Full Text] [PDF]

				G. Hay, H. Refsum, A. Whitelaw, E. L. Melbye, E. Haug, and B. Borch-Iohnsen Predictors of serum ferritin and serum soluble transferrin receptor in newborns and their associations with iron status during the first 2 y of life Am. J. Clinical Nutrition, July 1, 2007; 86(1): 64 - 73. [Abstract] [Full Text] [PDF]

				T. O Scholl, X. Chen, M. Sims, and T P. Stein Vitamin E: maternal concentrations are associated with fetal growth Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1442 - 1448. [Abstract] [Full Text] [PDF]

				E. Devrim, I. Tarhan, I. B. Erguder, and I. Durak Oxidant/Antioxidant Status of Placenta, Blood, and Cord Blood Samples From Pregnant Women Supplemented With Iron Reproductive Sciences, October 1, 2006; 13(7): 502 - 505. [Abstract] [PDF]